<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The transcription factor TWIST-1 is up-regulated in CD34(+) cells in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and is involved in resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>There is evidence that TWIST-1 affects <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via microRNAs (miRs) </plain></SENT>
<SENT sid="2" pm="."><plain>Expression of miRs was determined in myeloid cell lines and primary CD34(+) marrow cells from patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and healthy donors using NanoString/array and validated by real-time-polymerase chain reaction </plain></SENT>
<SENT sid="3" pm="."><plain>Expression levels of miR10a and miR10b were significantly higher in CD34(+) marrow cells from 28 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> than in CD34(+) cells from healthy donors (P=0.05 and P=0.012, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>Levels of miR10a/b correlated with TWIST-1 miR levels in CD34(+) myelodysplastic marrow cells (miR10a, R=+0.69, P&lt;0.0001; miR10b, R=+0.56, P=0.0008) </plain></SENT>
<SENT sid="5" pm="."><plain>Inhibition of miR10a/10b in clonal cells interfered with proliferation and enhanced sensitivity to <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, which involved NF-ÎºB-dependent p53 activation </plain></SENT>
<SENT sid="6" pm="."><plain>These data support a role for miR10a/10b in the regulation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and suggest the TWIST-1/miR10a/b-axis as a therapeutic target in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
</text></document>